Licensing fees can also be quite significant: Rockefeller University received $20 million in upfront royalties from Amgen in 1995 for an exclusive license of the mouse leptin gene (22) , and Northwestern University sold its royalty rights for Lyrica (Pfizer, New York, New York) for $700 million (10) .
← all excerpts
Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process.
1
—
—